PLEASE REVIEW OUR PRIVACY & COOKIES NOTICE

We use cookies to collect and analyze information on site performance and usage and to ensure you can successfully navigate throughout the site.   By clicking the “ACCEPT” button to your right or by clicking on any site content, you agree to the placement of cookies on your computer.  For more information, see our Privacy Policy. 

 
Locations
 
WEBSITES
  • United States (English)
  • International (English)
  • Chinese (中文)
  • French (Français)
  • German (Deutsch)
  • Italian (Italiano)
  • Japanese (日本語)
  • Russian (Русский)
 

Leaving U.S. website

You are now leaving the Haemonetics U.S. website, click 'Yes' to continue or 'No' to stay on the U.S. website.

YesNo
  • Investor Relations
  • LOGIN
    • Haemonetics
    • HSS Client Login
    • Software Download Center
  • REGISTER
  • Home
  • Products
     
    U.S. ProductsView International Products
    Devices
    Blood Center Devices
    • ACP 215
    • MCS+ 8150
    • MCS+ 9000
    • NexSys PCS
    • PCS 2
    Plasma Center Devices
    • NexSys PCS with Persona Technology
    • NexSys PCS with YES Technology
    • NexSys PCS
    • PCS 2
    Surgical and Diagnostic Devices
    • Cell Saver Elite+
    • Cell Saver 5+
    • Cell Saver Elite
    • TEG
    Software
    Hospital Software
    • BloodTrack
    • SafeTrace Tx
    Plasma Center Software
    • DMS
    • NexLynk DMS
    • NextGen
    Services
    Consulting Services
    • Process Improvement
     
  • Solutions
     
    Blood Management Solutions
    • Solutions for Blood Centers
    • Solutions for Hospitals
    • Solutions for Plasma Centers
     
  • Learning Center
     
    Product Training
    • All Products
    • Blood Centers
    • Hospitals
    • Plasma Centers
    Thought Leadership
    • White Papers & Clinical Reviews
    • Reference Lists
    • Poster Abstracts
    Education
       
    • About Haemonetics
       
      Company Background
      • Overview
      • Historical Timeline
      • Leadership Team
      • Scientific Advisory Council

      • Office Locations
      Investor Relations
      • Investor Relations Home
      • Stock Information
      • Earnings
      • Forecasts & Guidance
      Corporate Responsibility
      • Corporate Responsibility at Haemonetics
      Donors Make It Matter
      • Donors Make It Matter Campaign
      News & Events
      • In the News
      • Calendar of Events
      • Publications
      Careers
      • Careers Overview
      • Open Positions
      • Our Global HQ

      Grants

      • Grant Program

       
    • Customer Support

    Leaving U.S. website

    You are now leaving the Haemonetics U.S. website, click 'Yes' to continue or 'No' to stay on the U.S. website.

    YesNo
    • Home
    • About Haemonetics
    • Corporate Responsibility
    • Corporate Responsibility at Haemonetics
    • Our Environment Health and Safety
    • Contact Us
    • Print
    • Share

    Our Environment, Health and Safety

    Our Environment, Health and Safety. We are committed to operating responsibly, conserving resources and meeting all environmental requirements that apply to us. As a Company, we are also committed to making our workplaces safe and secure. This includes eliminating unsafe work practices and workplace injuries and illnesses and promoting the health, safety and well-being of all employees, contractors and visitors. Important objectives in achieving our vision include: creating a positive safety culture, maintaining an effective safety management system and reducing risk in the workplace.

    Examples of how we deliver:

    • In fiscal 2020, we reduced our headquarters footprint by relocating from a 224,000 square foot campus in Braintree, Massachusetts to a 62,000 square foot LEED and Energy Star certified office space in Boston, Massachusetts.
    • We engage in energy/water efficiency, pollution prevention and waste reduction at multiple manufacturing sites – including our Utah, Pennsylvania and Mexico facilities – by increasing production efficiency and recycling qualified waste streams, including plastics, corrugate, paper wood pallets and aluminum cans. These actions in some cases create a circular economic model as vendors purchased materials for reuse. Our Utah facility utilizes a closed loop water system where water is treated, circulated and conserved to avoid high volumes of wastewater.
    • In fiscal 2020, we launched our Operational Excellence Program to improve our manufacturing and supply productivity and ensure sustainability and scalability, while reducing cost principally in the Company’s manufacturing and supply chain, including through scrap reduction, optimizing logistics routes for freight and shipping and the reduction and re-use of spare parts where appropriate.
    • We maintain an Environment, Health and Safety Policy approved by senior management that reflects our commitment to, among other things, comply with applicable laws, train our employees to work in a safe and environmentally responsible manner, and manage our operations in a socially responsible manner that reduces adverse environmental impacts in our communities.

    For additional information:

    • See “Environmental Protection” and “Health and Safety” under our Code of Conduct
    • Contact Us
    • Terms of Use
    • Quality
    • Careers
    • Privacy Policy
    • Site Map

    © 2011-2020 Haemonetics Corporation